Single‐nucleotide polymorphism rs13426236 contributes to an increased prostate cancer risk via regulating MLPH splicing variant 4

Abstract

A prostate cancer risk single-nucleotide polymorphism (SNP), rs13426236, is significantly associated with melanophilin (MLPH) expression. To functionally characterize role of the rs13426236 in prostate cancer, we first performed splicing-specific expression quantitative trait loci analysis and refined the significant association of rs13426236 allele G with an increased expression of MLPH splicing transcript variant 4 (V4) (P = 7.61E−5) but not other protein-coding variants (V1-V3) (P > .05). We then performed an allele-specific reporter assay to determine if SNP-containing sequences functioned as an active enhancer.Compared to allele A, allele G of rs13426236 showed significantly higher luciferase activity on the promoter of the splicing transcript V4 (P < .03) but not on the promoter of transcript V1 (P > .05) in two prostate cancer cell lines (DU145 and 22Rv1). Cell transfection assays showed stronger effect of transcript V4 than V1 on promoting cell proliferation, invasion, and antiapoptotic activities. RNA profiling analysis demonstrated that transcript V4 overexpression caused significant expression changes in glycosylation/ glycoprotein and metal-binding gene ontology pathways (FDR < 0.01). We also found that both transcripts V4 and V1 were significantly upregulated in prostate adenocarcinoma (P ≤ 2.49E−6) but only transcript V4 upregulation was associated with poor recurrencefree survival (P = .028, hazard ratio = 1.63, 95% confidence interval = 1.05-2.42) in The Cancer Genome Atlas data. This study provides strong evidence showing that prostate cancer risk SNP rs13426236 upregulates expression of MLPH transcript V4, which may function as a candidate oncogene in prostate cancer.

Proteomics-Derived Biomarker Panel Facilitates Distinguishing Primary Lung Adenocarcinomas With Intestinal or Mucinous Differentiation From Lung Metastatic Colorectal Cancer

“…MLPH is an important component involved in the transport of melanin, which contributes to visible pigmentation of hair and skin ( 49 , 50 ). While its role in cancer is not well understood, recent research has found that MLPH is associated with tumor development and metastasis in skin, breast, and prostate cancer ( 51 , 52 , 53 , 54 , 55 ). Meanwhile, several studies demonstrated that MLPH was highly expressed in lung adenocarcinoma but not in squamous cell carcinoma, indicating that MLPH could be a potential marker for differential diagnosis ( 56 , 57 , 58 ).…”

MDR 1 C3435T Gene Polymorphism in Colorectal Cancer

“…These factors could be influenceable such as lifestyle and dietary habits but also not influenceable like genetic susceptibility [2,4]. Several studies prove that single nucleotide polymorphism (SNP) of some genes may contribute to an increased or decreased cancer risk [5,6]. Among those SNPs, the ABCB1/MDR1 gene seems to play an important role in tumor progression [7].…”

A single-nucleotide polymorphism involved in alternative splicing of PTEN is associated with chemotherapy resistance in breast cancer in Chinese population

“…The PTEN gene has multiple SNPs and is a highly polymorphic gene, and pathogenic germline mutations are found in all 9 exons [20]. In recent years there are several reports that polymorphism can affect the process of alternative splicing, which lead to the occurrence and development of many human diseases [21][22][23]. The process of AS is affected by many factors, among which the in uence of the 3'and 5'splice site sequence of the branch point is common [24].…”